Jumpcode Genomics

View the org chart displaying its 10 main executives

Most searched biographies at Jumpcode Genomics

• Mike Salter, President and Chief Executive Officer
• Dan Kidle, Director
• Frank Witney, Chairman of the Board

Create your alert
to follow the executive moves at Jumpcode Genomics.

Jumpcode Genomics has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).
• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Jumpcode Genomics

Social media about Jumpcode Genomics

• Jumpcode Genomics on Wikipedia, Google News & Yahoo Finance
• Jumpcode Genomics on LinkedIn, Twitter & YouTube

Contact by email its executives including Mike Salter

Call Jumpcode Genomics at +1 619...

View the org chart

Register to receive your alert

Report an error